Novalon SA
Ouverture de faillite 5.0 FTENovalon reported revenue of €14.2m for the 2022 financial year (annual accounts filed with the NBB on 24 Jul 2023), with 5 full-time equivalents.
The score of Novalon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2019 → 2022: Revenue +311 % Total assets +15 % Headcount (avg FTE) -29 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novalon's annual accounts
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenue | €14.2m | ||||
| Net result | −€28.1m | ||||
| Equity | €9.22m | ||||
| Cash | 18,495 € | ||||
| EBITDA | −€15.6m | ||||
| Total assets | €36.6m |
Filed annual accounts
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
- Year ended 31 Dec 2020filed on 26 Jul 2021
- Year ended 31 Dec 2019filed on 13 Jul 2020
- Year ended 31 Dec 2018filed on 28 Jun 2019
Novalon's financial analysis
- Solvency25.2%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novalon
Novalon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.126.557
- VAT number
- BE0877126557
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 03 Nov 2005
- Registered office
- 4000 Liège
- Size
- Micro · 5.0 FTE
- Latest accounts
- 2022 · filed on 24 Jul 2023
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Novalon (SA) has been based in Liège since 2005, active in: manufacture of other pharmaceutical products. For 2022, it reports revenue of €14.2m, a net loss of €28.1m and equity of €9.22m. With 5.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 25.2%, below the median of its sector (34.4%).
Companies similar to Novalon
Companies in the same business, of comparable size and area, outside its group.
- Medgenix Benelux Manufacture of pharmaceutical preparations Wevelgem · balance sheet €39.4m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
- KELA - Kempisch Laboratorium - Kela Laboratoria Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €63.2m
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Odyssea Pharma Manufacture of pharmaceutical preparations Grâce-Hollogne · balance sheet €91.0m
- Hyloris Developments Manufacture of pharmaceutical preparations Liège · balance sheet €20.6m
- V.M.D. Manufacture of pharmaceutical preparations Arendonk · balance sheet €28.5m
- Novo Nordisk Production Belgium SA Manufacture of pharmaceutical preparations Brussels · balance sheet €153.5m
Frequently asked questions about Novalon
What is the revenue of Novalon?
According to the 2022 annual accounts filed with the NBB, the revenue of Novalon amounts to 14,215,303 €.
What is the VAT number of Novalon?
In Belgium, the VAT number is the company number prefixed with BE: BE0877126557 for Novalon, if the company is VAT-registered. Its company number (CBE) is 0877.126.557.
Where is the registered office of Novalon?
According to the CBE register, the registered office of Novalon is in 4000 Liège.
What is the equity of Novalon?
At the close of the 2022 financial year, the equity of Novalon amounts to 9,221,509 €, a solvency of 25.2% of total assets.
How many people work at Novalon?
5.0 full-time equivalents on average according to the 2022 social balance sheet.
Who manages Novalon?
The register lists 6 active mandates at Novalon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Novalon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →